InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by CAUSEY CHRISTOPHER, Director. Officer active across 1 companies, notably UNITED THERAPEUTICS Corp. Aggregated, 9 disclosures have been recorded. The latest transaction was filed on 9 September 2024 — Don. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
0225 shares0
Common Stock
SEC:0001237334-25-000005·
0225 shares0
Common Stock
SEC:0001237334-25-000005:0·
€360,8395,000 shares@ €72.16780.0015% mcap34.3% of flow
Common Stock
SEC:0001415889-22-007024:0·
075 shares0
Common Stock
SEC:0001415889-22-005904:0·
€355,7275,000 shares@ €71.14540.0015% mcap33.8% of flow
Common Stock
SEC:0001415889-22-005700:0·
€168,3882,610 shares@ €64.51660.0007% mcap100.0% of flow
Common Stock
SEC:0001127602-21-023274·
€168,3882,610 shares@ €64.51660.0007% mcap16.0% of flow
Common Stock
SEC:0001127602-21-023274:0·
075 shares0
Common Stock
SEC:0001127602-21-018328·
075 shares0
Common Stock
SEC:0001127602-21-018328:0·
9 of 9 declarations
About CAUSEY CHRISTOPHER
Christopher Causey is a Director at United Therapeutics Corp. In this role, he participates in the governance of the company and contributes to strategic decision-making. His experience is valuable in guiding the company in its growth initiatives.
